About Us
Revolutionary Company with Revolutionary Therapies.
![](https://revolobio.com/wp-content/uploads/Powerbutton.png)
Our Leadership Team
We are on a mission to change the lives of people with autoimmune and allergic diseases by developing therapies that reset the immune system to achieve long-term disease remission. Revolo Biotherapeutics (“Revolo Bio”) has a global footprint, with headquarters in both Gaithersburg, MD, in the US, and London in the United Kingdom.
Our team of accomplished industry professionals has a track record of success in funding and executing drug development and commercialization plans. We are ready to revolutionize autoimmune and allergic disease treatment!
Management
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Jones Bryan](https://revolobio.com/wp-content/uploads/Jones-Bryan.png)
![Jones Bryan](https://revolobio.com/wp-content/uploads/Jones-Bryan-Hover.png)
Jones W Bryan, ph.d.
President & Chief Executive Officer
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Jonathan Gold](https://revolobio.com/wp-content/uploads/Jonathan-Gold.png)
![Jonathan Gold](https://revolobio.com/wp-content/uploads/Jonathan-Gold-Hover.png)
Jonathan Gold
Chief Financial Officer
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Dr Roly Foulkes](https://revolobio.com/wp-content/uploads/Dr_Roly_Foulkes.png)
![Roly Poulkes](https://revolobio.com/wp-content/uploads/Roly-Poulkes-Hover.png)
Dr. Roly Foulkes
Chief Scientific Officer
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Beth Alley](https://revolobio.com/wp-content/uploads/beth-alley.png)
![](https://revolobio.com/wp-content/uploads/beth-alley-hover.png)
Beth Alley
Vice President, Regulatory Affairs
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Femi Oluboyede](https://revolobio.com/wp-content/uploads/Femi-Oluboyede.png)
![Femi Oluboyede](https://revolobio.com/wp-content/uploads/Femi-Oluboyede-fun-alt.png)
Femi Oluboyede
Vice President, Technical Operations, CMC
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Kari Brown](https://revolobio.com/wp-content/uploads/Kari-Brown-1.png)
![](https://revolobio.com/wp-content/uploads/Kari-Brown-burst.png)
Kari Brown, M.D.
Executive Vice President, Clinical Development, Operations and Strategy
Board of Directors
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![David Southwell](https://revolobio.com/wp-content/uploads/David-Southwell-color-sm.png)
David Southwell
Chairman
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Peter Greenleaf](https://revolobio.com/wp-content/uploads/Peter-Greenleaf-BOD.png)
Peter Greenleaf
Non-Executive Director
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Isaac Cheng](https://revolobio.com/wp-content/uploads/Isaac-Cheng-BOD.png)
Dr. Isaac Cheng
Non-Executive Director
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Michael Albisser](https://revolobio.com/wp-content/uploads/Michael-Albisser-BOD.png)
Michael Albisser
Non-Executive Director
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Marla Persky](https://revolobio.com/wp-content/uploads/Marla-Persky.png)
Marla S. Persky
Non-Executive Director
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![Glen Giovanetti](https://revolobio.com/wp-content/uploads/Glen.png)
Glen Giovanetti
Non-Executive Director
![](https://revolobio.com/wp-content/uploads/bio-elipse.png)
![](https://revolobio.com/wp-content/uploads/TundeOtulana.png)